Articles Tagged With:
-
Liability Protections for EMTALA Care Elusive for EPs
Although several states have enacted liability reform legislation for ED care, efforts at the federal level have been less successful. Here is a summary of legislation under consideration in Congress.
-
Visit Volume Linked to Being Named in Claim
One in 11 EPs was named in malpractice claims during a 4.5 year period, according to a recent study. Total number of years in practice and visit volume were the only factors associated with being named as a defendant.
-
When Psychiatric Patient Comes to ED, Consider Entire Hospital’s Capabilities
An attorney who worked on the case provides detailed information about a recent record-breaking EMTALA settlement.
-
Inspector General Sets Sights on ED Psychiatric Boarding Practices
Psychiatric patients are held routinely in EDs for hours, days, or even weeks due to lack of available facilities. Few would argue it’s a high-risk situation for the patient, EPs, and the hospital; yet, the dangerous practice continues.
-
Non-prudent Limits on Patient Visits: Overcoming Barriers to Provide Necessary Care
Since EMTALA requires medical professionals to provide care to their patients, big insurance companies see no reason to provide payment for care they do not feel like covering. While some argue that on the surface this is their right to pay only for necessary services, the decision to retrospectively deny coverage is a fundamental assault on the rights of patients to seek emergency care and providers to bill for legitimate services rendered. Using the “retrospectoscope” to lecture patients and providers about care for serious health threats is a disservice to all medical professionals. It is unconscionable, immoral, illegal, and potentially unconstitutional.
-
Clinical Briefs
In this section: A better definition for celiac disease; shedding light on a vaccine; and treating asthma.
-
Meropenem and Vaborbactam Injection (Vabomere)
The FDA has approved a new combination antibacterial for the treatment of complicated urinary tract infections.
-
Is a Dabigatran Reversal Agent Effective?
A pragmatic clinical study of idarucizumab for counteracting the effects of the oral anticoagulant dabigatran showed rapid and complete reversal of its effects in patients with major bleeding or urgent surgery, without any adverse safety concerns.
-
Mother Was Right: You Are What You Eat
In a study of simplified enterotypes as prognostic markers for successful body fat loss on two different diets, participants with a greater ratio of Prevotella to Bacteroides appeared more susceptible to lose body fat on diets high in fiber and whole grains.
-
Diet High in Carbohydrates, Not Fats, Drives Mortality
A prospective epidemiological cohort study of people 35-70 years of age in 18 countries showed that a higher intake of carbohydrates increased total mortality, while the intake of fats of all kinds did not. A higher intake of saturated fat reduced stroke mortality.